2 results
Approved WMOCompleted
This clinical trial will test the safety and performance of the Spinal Modulation Neurostimulator System in the treatment of chronic pain.Outcomes:Primary Outcomes: 1) Safety as determined by adverse event reporting2) Device performance as…
Approved WMOCompleted
This is a phase I study of hydroxyurea and dose-intense temozolomide in patients with recurrent glioblastoma that are elegise for re-challenge temozolomide.Primary Objective: To determine the maximal tolerated dose and safety profile of daily…